SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Short Interest Update

Posted by Trevor Kearing on Mar 4th, 2026

SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH – Get Free Report) was the target of a large increase in short interest in February. As of February 13th, there was short interest totaling 781,872 shares, an increase of 21.1% from the January 29th total of 645,905 shares. Based on an average trading volume of 119,993 shares, the short-interest ratio is currently 6.5 days. Approximately 15.0% of the shares of the stock are short sold. Approximately 15.0% of the shares of the stock are short sold. Based on an average trading volume of 119,993 shares, the short-interest ratio is currently 6.5 days.

SPDR S&P Pharmaceuticals ETF Stock Down 3.2%

NYSEARCA:XPH opened at $55.71 on Wednesday. The firm has a market capitalization of $289.69 million, a PE ratio of 14.28 and a beta of 0.60. SPDR S&P Pharmaceuticals ETF has a 12-month low of $35.22 and a 12-month high of $58.84. The firm has a 50-day moving average price of $56.66 and a 200 day moving average price of $52.27.

Hedge Funds Weigh In On SPDR S&P Pharmaceuticals ETF

Several hedge funds and other institutional investors have recently modified their holdings of XPH. Advisory Services Network LLC acquired a new stake in SPDR S&P Pharmaceuticals ETF in the 3rd quarter valued at $34,000. Team Financial Group LLC acquired a new position in SPDR S&P Pharmaceuticals ETF during the fourth quarter worth $56,000. Kestra Advisory Services LLC bought a new position in shares of SPDR S&P Pharmaceuticals ETF during the fourth quarter valued at $151,000. Vista Investment Management acquired a new stake in shares of SPDR S&P Pharmaceuticals ETF in the 4th quarter valued at $223,000. Finally, Stephens Inc. AR acquired a new stake in shares of SPDR S&P Pharmaceuticals ETF in the 4th quarter valued at $229,000.

About SPDR S&P Pharmaceuticals ETF

(Get Free Report)

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.